Randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

对冰毒(冰毒)的上瘾是一个日益严重的社区问题，与严重的疾病和死亡有关。目前的咨询方法本身成效有限，需要与药物相关的更有效的治疗。利塞非他明是一种新批准的兴奋剂药物，在治疗这些患者方面前景广阔。这项试验将检查左旋氨非他明(通过咨询)是否安全地减少甲基苯丙胺的使用，并改善重度吸毒者的健康和福祉。

Addiction to methamphetamines (‘ice’) is a growing community problem linked to serious disease and death. Current counselling approaches have limited success on their own, and more effective treatments linked to medications are needed. Lisdexamfetamine is a newly licenced stimulant medication with great promise in treating these patients. This trial will examine whether lisdexamfetamine (with counselling) safely reduces methamphetamine use and improves health and wellbeing among heavy users.